CD8A and melanoma: In this study, replication-incompetent rHuAd5 vectors expressing the melanoma antigen, human dopachrome tautomerase (hDCT), generated modest frequencies of hDCT-specific CD8+ T cells (~3%) in B16.F10 tumour-bearing animals to achieve a significant survival extension, but no durable cures.